In an April 6 initiation report, Haywood analyst Neal Gilmer launched coverage of Cannara Biotech (Cannara Biotech Stock Quote, Chart, News, Analysts, Financials TSXV:LOVE) with a “Buy” rating and a $3.00 target, saying the company’s steady market share gains, profitable growth and disciplined expansion strategy set it apart in the Canadian cannabis sector. Gilmer said Cannara […]
In an April 2 report, Haywood analyst Neal Gilmer cut his target on Tilray Brands (Tilray Brands Stock Quote, Chart, News, Analysts, Financials NASDAQ:TLRY) to $7.40 from $10.50 and maintained his “Hold” rating after third-quarter fiscal 2026 results that came in broadly in line with expectations. He said Tilray remains a significant player in Canadian […]
Share
Tweet
Share
